Selumetinib (Koselugo)

From HemOnc.org - A Hematology Oncology Wiki

Revision as of 15:10, 19 September 2014 by Jwarner (talk | contribs)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Jump to navigation Jump to search

Mechanism of action

Inhibits the enzyme MAPK kinase (MEK), specifically the MEK1 and MEK2 subtypes of the enzyme.

Diseases for which it is used

Acute myeloid leukemia

Retrieved from "https://hemonc.org/w/index.php?title=Selumetinib_(Koselugo)&oldid=5065"